Amgen Inc. (AMGN)

Nasdaq · Health Care · Biotechnology

Key financials

Revenue
$38.1 billion
Operating margin
30.0%
Net margin
23.0%
Free cash flow
$10.2 billion

12 months to · Definitions

Last close $445.65 on Mon Oct 26 · Chart: daily closes, adjusted for splits

About Amgen Inc.

Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes prescription biologic medicines and other therapies, generating revenue primarily from product sales to wholesalers/distributors, hospitals…

Headquarters
THOUSAND OAKS, CA, United States
Website
amgen.com

AMGN stories

RSS for AMGN